Wei Chen,Sara Perrotta,Liang Xiao,Lorenzo Carnevale,Marwa A Abd-ElDayem,Elizabeth M Hennen,Luis Miguel Rivera-Medina,David M Patrick,Mingfang Ao,Fabio Pallante,Azzurra Zonfrilli,Shilin Zhao,Agnese Migliaccio,Lan Lan,Stefania Fardella,Giuseppe Sciumè,Francesco Mastroiacovo,Giuseppe Lembo,Daniela Carnevale,David G Harrison
{"title":"Beta 2 adrenergic receptor gene methylation activates innate lymphoid cells to drive hypertension in lymphocyte deficient hosts.","authors":"Wei Chen,Sara Perrotta,Liang Xiao,Lorenzo Carnevale,Marwa A Abd-ElDayem,Elizabeth M Hennen,Luis Miguel Rivera-Medina,David M Patrick,Mingfang Ao,Fabio Pallante,Azzurra Zonfrilli,Shilin Zhao,Agnese Migliaccio,Lan Lan,Stefania Fardella,Giuseppe Sciumè,Francesco Mastroiacovo,Giuseppe Lembo,Daniela Carnevale,David G Harrison","doi":"10.1093/cvr/cvaf042","DOIUrl":null,"url":null,"abstract":"AIMS\r\nT cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency.\r\n\r\nMETHODS AND RESULTS\r\nWe studied two colonies of T/B cell-deficient RAG-1-/- mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1-/- mice to expand natural killer and innate lymphoid cells (NK/ILCs) that produce pro-hypertensive cytokines. This process is regulated by the DNA methylation status of the β2 adrenergic receptor (β2-AdR). Angiotensin II caused blood pressure elevation in T and NK/ILCs-deficient mice only when either T or NK/ILCs cells were adoptively reconstituted. Additional studies showed NK cell expansion in humans that underwent B cell depletion, and this was augmented in those with hypertension.\r\n\r\nCONCLUSIONS\r\nThese findings illustrate that the modulation of NK/ILCs activation by adrenergic signalling governs an escape mechanism in lymphocyte-deficient host, enabling the development of hypertension.","PeriodicalId":9638,"journal":{"name":"Cardiovascular Research","volume":"183 1","pages":""},"PeriodicalIF":10.2000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cvr/cvaf042","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
AIMS
T cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency.
METHODS AND RESULTS
We studied two colonies of T/B cell-deficient RAG-1-/- mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1-/- mice to expand natural killer and innate lymphoid cells (NK/ILCs) that produce pro-hypertensive cytokines. This process is regulated by the DNA methylation status of the β2 adrenergic receptor (β2-AdR). Angiotensin II caused blood pressure elevation in T and NK/ILCs-deficient mice only when either T or NK/ILCs cells were adoptively reconstituted. Additional studies showed NK cell expansion in humans that underwent B cell depletion, and this was augmented in those with hypertension.
CONCLUSIONS
These findings illustrate that the modulation of NK/ILCs activation by adrenergic signalling governs an escape mechanism in lymphocyte-deficient host, enabling the development of hypertension.
期刊介绍:
Cardiovascular Research
Journal Overview:
International journal of the European Society of Cardiology
Focuses on basic and translational research in cardiology and cardiovascular biology
Aims to enhance insight into cardiovascular disease mechanisms and innovation prospects
Submission Criteria:
Welcomes papers covering molecular, sub-cellular, cellular, organ, and organism levels
Accepts clinical proof-of-concept and translational studies
Manuscripts expected to provide significant contribution to cardiovascular biology and diseases